Top compounds associated with response to ARL17B


Feature Type Standardized
Nominal ANOVA
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-06
mRNA manumycin A CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 5e-06
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.13 7e-06
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.15 7e-06
mRNA NSC95397 CTRPv2 pan-cancer AAC 0.15 9e-06
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA PL-DI CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA CAL-101 GDSC1000 pan-cancer AAC 0.13 2e-05
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.14 2e-05
Download CSV